aluates Reports

$ 0.0

Automative

Global Gene Silencing Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-24W5661

Global Gene Silencing Market Insights Forecast to 2028

BUY CHAPTERS

Global Gene Silencing Market Research Report 2025

Code: QYRE-Auto-24W5661

Report

June 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alnylam Pharmaceuticals

Benitec Biopharma

Arrowhead Pharmaceuticals

Merck Group

Eli Lilly (Dicerna Pharmaceuticals)

Monsanto (Bayer AG)

RXi Pharmaceuticals

Silence Therapeutics Plc

Idera Pharmaceuticals

Gene Silencing Market

The global market for Gene Silencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research.In particular, methods used to silence genes are being increasingly used to produce therapeutics to combat cancer and diseases, such as infectious diseases and neurodegenerative disorders.

North American market for Gene Silencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Gene Silencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Gene Silencing in Cancer Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Gene Silencing include Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pharmaceuticals, Merck Group, Eli Lilly (Dicerna Pharmaceuticals), Monsanto (Bayer AG), RXi Pharmaceuticals, Silence Therapeutics plc, Idera Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gene Silencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Silencing.

The Gene Silencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Silencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Silencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Silencing Market Report

Report Metric	Details
Report Name	Gene Silencing Market
Segment by Type	Transcriptional Post-transcriptional Meiotic
Segment by Application	Cancer Treatment Neurological Diseases Treatment Scar Treatment Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pharmaceuticals, Merck Group, Eli Lilly (Dicerna Pharmaceuticals), Monsanto (Bayer AG), RXi Pharmaceuticals, Silence Therapeutics plc, Idera Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Silencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Silencing Market report?

Ans: The main players in the Gene Silencing Market are Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pharmaceuticals, Merck Group, Eli Lilly (Dicerna Pharmaceuticals), Monsanto (Bayer AG), RXi Pharmaceuticals, Silence Therapeutics plc, Idera Pharmaceuticals

What are the Application segmentation covered in the Gene Silencing Market report?

Ans: The Applications covered in the Gene Silencing Market report are Cancer Treatment, Neurological Diseases Treatment, Scar Treatment, Other

What are the Type segmentation covered in the Gene Silencing Market report?

Ans: The Types covered in the Gene Silencing Market report are Transcriptional, Post-transcriptional, Meiotic

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Silencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Transcriptional

1.2.3 Post-transcriptional

1.2.4 Meiotic

1.3 Market by Application

1.3.1 Global Gene Silencing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer Treatment

1.3.3 Neurological Diseases Treatment

1.3.4 Scar Treatment

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Silencing Market Perspective (2020-2031)

2.2 Global Gene Silencing Growth Trends by Region

2.2.1 Global Gene Silencing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Silencing Historic Market Size by Region (2020-2025)

2.2.3 Gene Silencing Forecasted Market Size by Region (2026-2031)

2.3 Gene Silencing Market Dynamics

2.3.1 Gene Silencing Industry Trends

2.3.2 Gene Silencing Market Drivers

2.3.3 Gene Silencing Market Challenges

2.3.4 Gene Silencing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Silencing Players by Revenue

3.1.1 Global Top Gene Silencing Players by Revenue (2020-2025)

3.1.2 Global Gene Silencing Revenue Market Share by Players (2020-2025)

3.2 Global Gene Silencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Silencing Revenue

3.4 Global Gene Silencing Market Concentration Ratio

3.4.1 Global Gene Silencing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Silencing Revenue in 2024

3.5 Global Key Players of Gene Silencing Head office and Area Served

3.6 Global Key Players of Gene Silencing, Product and Application

3.7 Global Key Players of Gene Silencing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Silencing Breakdown Data by Type

4.1 Global Gene Silencing Historic Market Size by Type (2020-2025)

4.2 Global Gene Silencing Forecasted Market Size by Type (2026-2031)

5 Gene Silencing Breakdown Data by Application

5.1 Global Gene Silencing Historic Market Size by Application (2020-2025)

5.2 Global Gene Silencing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Silencing Market Size (2020-2031)

6.2 North America Gene Silencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Silencing Market Size by Country (2020-2025)

6.4 North America Gene Silencing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Silencing Market Size (2020-2031)

7.2 Europe Gene Silencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Silencing Market Size by Country (2020-2025)

7.4 Europe Gene Silencing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Silencing Market Size (2020-2031)

8.2 Asia-Pacific Gene Silencing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Silencing Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Silencing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Silencing Market Size (2020-2031)

9.2 Latin America Gene Silencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Silencing Market Size by Country (2020-2025)

9.4 Latin America Gene Silencing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Silencing Market Size (2020-2031)

10.2 Middle East & Africa Gene Silencing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Silencing Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Silencing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alnylam Pharmaceuticals

11.1.1 Alnylam Pharmaceuticals Company Details

11.1.2 Alnylam Pharmaceuticals Business Overview

11.1.3 Alnylam Pharmaceuticals Gene Silencing Introduction

11.1.4 Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2020-2025)

11.1.5 Alnylam Pharmaceuticals Recent Development

11.2 Benitec Biopharma

11.2.1 Benitec Biopharma Company Details

11.2.2 Benitec Biopharma Business Overview

11.2.3 Benitec Biopharma Gene Silencing Introduction

11.2.4 Benitec Biopharma Revenue in Gene Silencing Business (2020-2025)

11.2.5 Benitec Biopharma Recent Development

11.3 Arrowhead Pharmaceuticals

11.3.1 Arrowhead Pharmaceuticals Company Details

11.3.2 Arrowhead Pharmaceuticals Business Overview

11.3.3 Arrowhead Pharmaceuticals Gene Silencing Introduction

11.3.4 Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2020-2025)

11.3.5 Arrowhead Pharmaceuticals Recent Development

11.4 Merck Group

11.4.1 Merck Group Company Details

11.4.2 Merck Group Business Overview

11.4.3 Merck Group Gene Silencing Introduction

11.4.4 Merck Group Revenue in Gene Silencing Business (2020-2025)

11.4.5 Merck Group Recent Development

11.5 Eli Lilly (Dicerna Pharmaceuticals)

11.5.1 Eli Lilly (Dicerna Pharmaceuticals) Company Details

11.5.2 Eli Lilly (Dicerna Pharmaceuticals) Business Overview

11.5.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Introduction

11.5.4 Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2020-2025)

11.5.5 Eli Lilly (Dicerna Pharmaceuticals) Recent Development

11.6 Monsanto (Bayer AG)

11.6.1 Monsanto (Bayer AG) Company Details

11.6.2 Monsanto (Bayer AG) Business Overview

11.6.3 Monsanto (Bayer AG) Gene Silencing Introduction

11.6.4 Monsanto (Bayer AG) Revenue in Gene Silencing Business (2020-2025)

11.6.5 Monsanto (Bayer AG) Recent Development

11.7 RXi Pharmaceuticals

11.7.1 RXi Pharmaceuticals Company Details

11.7.2 RXi Pharmaceuticals Business Overview

11.7.3 RXi Pharmaceuticals Gene Silencing Introduction

11.7.4 RXi Pharmaceuticals Revenue in Gene Silencing Business (2020-2025)

11.7.5 RXi Pharmaceuticals Recent Development

11.8 Silence Therapeutics plc

11.8.1 Silence Therapeutics plc Company Details

11.8.2 Silence Therapeutics plc Business Overview

11.8.3 Silence Therapeutics plc Gene Silencing Introduction

11.8.4 Silence Therapeutics plc Revenue in Gene Silencing Business (2020-2025)

11.8.5 Silence Therapeutics plc Recent Development

11.9 Idera Pharmaceuticals

11.9.1 Idera Pharmaceuticals Company Details

11.9.2 Idera Pharmaceuticals Business Overview

11.9.3 Idera Pharmaceuticals Gene Silencing Introduction

11.9.4 Idera Pharmaceuticals Revenue in Gene Silencing Business (2020-2025)

11.9.5 Idera Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alnylam Pharmaceuticals

Benitec Biopharma

Arrowhead Pharmaceuticals

Merck Group

Eli Lilly (Dicerna Pharmaceuticals)

Monsanto (Bayer AG)

RXi Pharmaceuticals

Silence Therapeutics Plc

Idera Pharmaceuticals

List of Tables

Table 1. Global Gene Silencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Transcriptional

Table 3. Key Players of Post-transcriptional

Table 4. Key Players of Meiotic

Table 5. Global Gene Silencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Silencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gene Silencing Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gene Silencing Market Share by Region (2020-2025)

Table 9. Global Gene Silencing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gene Silencing Market Share by Region (2026-2031)

Table 11. Gene Silencing Market Trends

Table 12. Gene Silencing Market Drivers

Table 13. Gene Silencing Market Challenges

Table 14. Gene Silencing Market Restraints

Table 15. Global Gene Silencing Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gene Silencing Market Share by Players (2020-2025)

Table 17. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Silencing as of 2024)

Table 18. Ranking of Global Top Gene Silencing Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gene Silencing Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gene Silencing, Headquarters and Area Served

Table 21. Global Key Players of Gene Silencing, Product and Application

Table 22. Global Key Players of Gene Silencing, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Silencing Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gene Silencing Revenue Market Share by Type (2020-2025)

Table 26. Global Gene Silencing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gene Silencing Revenue Market Share by Type (2026-2031)

Table 28. Global Gene Silencing Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gene Silencing Revenue Market Share by Application (2020-2025)

Table 30. Global Gene Silencing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gene Silencing Revenue Market Share by Application (2026-2031)

Table 32. North America Gene Silencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gene Silencing Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gene Silencing Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gene Silencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gene Silencing Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gene Silencing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gene Silencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gene Silencing Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gene Silencing Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gene Silencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gene Silencing Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gene Silencing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gene Silencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gene Silencing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gene Silencing Market Size by Country (2026-2031) & (US$ Million)

Table 47. Alnylam Pharmaceuticals Company Details

Table 48. Alnylam Pharmaceuticals Business Overview

Table 49. Alnylam Pharmaceuticals Gene Silencing Product

Table 50. Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 51. Alnylam Pharmaceuticals Recent Development

Table 52. Benitec Biopharma Company Details

Table 53. Benitec Biopharma Business Overview

Table 54. Benitec Biopharma Gene Silencing Product

Table 55. Benitec Biopharma Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 56. Benitec Biopharma Recent Development

Table 57. Arrowhead Pharmaceuticals Company Details

Table 58. Arrowhead Pharmaceuticals Business Overview

Table 59. Arrowhead Pharmaceuticals Gene Silencing Product

Table 60. Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 61. Arrowhead Pharmaceuticals Recent Development

Table 62. Merck Group Company Details

Table 63. Merck Group Business Overview

Table 64. Merck Group Gene Silencing Product

Table 65. Merck Group Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 66. Merck Group Recent Development

Table 67. Eli Lilly (Dicerna Pharmaceuticals) Company Details

Table 68. Eli Lilly (Dicerna Pharmaceuticals) Business Overview

Table 69. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product

Table 70. Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 71. Eli Lilly (Dicerna Pharmaceuticals) Recent Development

Table 72. Monsanto (Bayer AG) Company Details

Table 73. Monsanto (Bayer AG) Business Overview

Table 74. Monsanto (Bayer AG) Gene Silencing Product

Table 75. Monsanto (Bayer AG) Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 76. Monsanto (Bayer AG) Recent Development

Table 77. RXi Pharmaceuticals Company Details

Table 78. RXi Pharmaceuticals Business Overview

Table 79. RXi Pharmaceuticals Gene Silencing Product

Table 80. RXi Pharmaceuticals Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 81. RXi Pharmaceuticals Recent Development

Table 82. Silence Therapeutics plc Company Details

Table 83. Silence Therapeutics plc Business Overview

Table 84. Silence Therapeutics plc Gene Silencing Product

Table 85. Silence Therapeutics plc Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 86. Silence Therapeutics plc Recent Development

Table 87. Idera Pharmaceuticals Company Details

Table 88. Idera Pharmaceuticals Business Overview

Table 89. Idera Pharmaceuticals Gene Silencing Product

Table 90. Idera Pharmaceuticals Revenue in Gene Silencing Business (2020-2025) & (US$ Million)

Table 91. Idera Pharmaceuticals Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Gene Silencing Picture

Figure 2. Global Gene Silencing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Silencing Market Share by Type: 2024 VS 2031

Figure 4. Transcriptional Features

Figure 5. Post-transcriptional Features

Figure 6. Meiotic Features

Figure 7. Global Gene Silencing Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gene Silencing Market Share by Application: 2024 VS 2031

Figure 9. Cancer Treatment Case Studies

Figure 10. Neurological Diseases Treatment Case Studies

Figure 11. Scar Treatment Case Studies

Figure 12. Other Case Studies

Figure 13. Gene Silencing Report Years Considered

Figure 14. Global Gene Silencing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Gene Silencing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Gene Silencing Market Share by Region: 2024 VS 2031

Figure 17. Global Gene Silencing Market Share by Players in 2024

Figure 18. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Silencing as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Gene Silencing Revenue in 2024

Figure 20. North America Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Gene Silencing Market Share by Country (2020-2031)

Figure 22. United States Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Gene Silencing Market Share by Country (2020-2031)

Figure 26. Germany Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Gene Silencing Market Share by Region (2020-2031)

Figure 34. China Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Gene Silencing Market Share by Country (2020-2031)

Figure 42. Mexico Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Gene Silencing Market Share by Country (2020-2031)

Figure 46. Turkey Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Gene Silencing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 50. Benitec Biopharma Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 51. Arrowhead Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 52. Merck Group Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 53. Eli Lilly (Dicerna Pharmaceuticals) Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 54. Monsanto (Bayer AG) Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 55. RXi Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 56. Silence Therapeutics plc Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 57. Idera Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Gene Therapy For Cancer Market Research Report 2024

Gene Expression and Transcriptome Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Editing Technology Market Research Report 2024

Global CRISPR Gene Editing Market Research Report 2024

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Gene Therapy Market Research Report 2025

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Cell Gene Overexpression Service Market Research Report 2024

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global Gene Therapy On Cardiovascular Disease Market Research Report 2025

Global RNA Gene Expression Sequencing Market Research Report 2024

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global Gene Expression Screening Service Market Research Report 2024

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global DNA and RNA Analysis Market Research Report 2024

Global Gene Expression Profiling Market Insights Forecast to 2030

Global Gene Expression Assay Service Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions